We would like to congratulate Megan McLeod and colleagues1 for the development of a contextually relevant cancer quality indicator set for low-income and middle-income countries (LMICs). From our own experience of developing a quality indicator set for critically ill patients, we are aware of the challenges of building consensus for measures of quality in lower-middle income contexts.2